Literature DB >> 24403297

Disability pension after coronary revascularization: a prospective nationwide register-based Swedish cohort study.

Katharina Zetterström1, Marjan Vaez2, Kristina Alexanderson2, Torbjörn Ivert3, Kenneth Pehrsson4, Niklas Hammar5, Margaretha Voss6.   

Abstract

BACKGROUND: Scientific knowledge on disability pension (DP) after revascularization by coronary artery bypass grafting (CABG) and percutaneous coronary intervention (PCI) is scarce. The aim was to study the incidence of and risk factors for being granted DP in the 5 years following a first CABG or PCI, accounting for socio-demographic and medical factors.
METHODS: This is a nationwide population-based study using Swedish registers including all patients 30-63 years of age (n = 34,643, 16.4% women) who had a first CABG (n = 14,107) or PCI (n = 20,536) during 1994-2003. All were alive and without reintervention 30 days after the procedure and were not on DP or old-age pension. Multivariable adjusted Cox proportional hazard ratios (HR) for DP were estimated with 95% confidence intervals (CI).
RESULTS: In 5 years following revascularization, 32.4% had been granted DP and the hazard ratio (HR) was higher in women (HR 1.55, 95% CI 1.48-1.62), and in CABG patients compared with PCI patients (HR 1.35, 95% CI 1.30-1.40). Long-term sick leave in the year before intervention was the strongest predictor for DP following revascularization. After adjustments for socio-demographic factors and sick-leave days in the 12 months before revascularization, HR remained high in all patients with diabetes mellitus regardless of type of revascularization.
CONCLUSIONS: DP after coronary revascularization was common, especially among women and CABG patients. Most studied medical covariates, including mental and musculoskeletal disorders, were risk factors for future DP, especially long-term sickness absence. © The European Society of Cardiology 2014 Reprints and permissions: sagepub.co.uk/journalsPermissions.nav.

Entities:  

Keywords:  Comorbidity; coronary revascularization; disability pension; insurance medicine; sick leave

Mesh:

Year:  2014        PMID: 24403297     DOI: 10.1177/2047487313518472

Source DB:  PubMed          Journal:  Eur J Prev Cardiol        ISSN: 2047-4873            Impact factor:   7.804


  5 in total

1.  Prevalence of all-cause and diagnosis-specific disability pension at the time of first coronary revascularisation: a population-based Swedish cross-sectional study.

Authors:  Katharina Zetterström; Margaretha Voss; Kristina Alexanderson; Torbjörn Ivert; Kenneth Pehrsson; Niklas Hammar; Marjan Vaez
Journal:  PLoS One       Date:  2015-01-28       Impact factor: 3.240

2.  Work disability before and after a major cardiovascular event: a ten-year study using nationwide medical and insurance registers.

Authors:  Marianna Virtanen; Jenni Ervasti; Ellenor Mittendorfer-Rutz; Tea Lallukka; Linnea Kjeldgård; Emilie Friberg; Mika Kivimäki; Erik Lundström; Kristina Alexanderson
Journal:  Sci Rep       Date:  2017-04-25       Impact factor: 4.379

3.  Trends in diagnosis-specific work disability before and after ischaemic heart disease: a nationwide population-based cohort study in Sweden.

Authors:  Jenni Ervasti; Marianna Virtanen; Tea Lallukka; Emilie Friberg; Ellenor Mittendorfer-Rutz; Erik Lundström; Kristina Alexanderson
Journal:  BMJ Open       Date:  2018-04-19       Impact factor: 2.692

4.  Sociodemographic, labour market marginalisation and medical characteristics as risk factors for reinfarction and mortality within 1 year after a first acute myocardial infarction: a register-based cohort study of a working age population in Sweden.

Authors:  Mo Wang; Marjan Vaez; Thomas Ernst Dorner; Syed Ghulam Rahman; Magnus Helgesson; Torbjörn Ivert; Ellenor Mittendorfer-Rutz
Journal:  BMJ Open       Date:  2019-12-18       Impact factor: 2.692

5.  Permanent work disability before and after ischaemic heart disease or stroke event: a nationwide population-based cohort study in Sweden.

Authors:  Jenni Ervasti; Marianna Virtanen; Tea Lallukka; Emilie Friberg; Ellenor Mittendorfer-Rutz; Erik Lundström; Kristina Alexanderson
Journal:  BMJ Open       Date:  2017-09-29       Impact factor: 2.692

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.